Jane Street’s Takeda Pharmaceutical TAK Stock Holding History

Jane Street’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-12,100	Closed	-$190K	–	9908
2022 Q4	$190K	Buy	+12,100	New	+$169K	﹤0.01%	7706
2022 Q2	–	Sell	-11,500	Closed	-$165K	–	10843
2022 Q1	$165K	Sell	11,500 -30,300	-72%	-$445K	﹤0.01%	9166
2021 Q4	$570K	Buy	41,800 +4,500	+12%	+$63.1K	﹤0.01%	7012
2021 Q3	$620K	Buy	37,300 +600	+2%	+$10.1K	﹤0.01%	6871
2021 Q2	$614K	Sell	36,700 -63,600	-63%	-$1.08M	﹤0.01%	6858
2021 Q1	$1.8M	Buy	100,300 +85,300	+569%	+$1.53M	﹤0.01%	4208
2020 Q4	$273K	Buy	+15,000	New	+$263K	﹤0.01%	6547

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jane Street's TAK Position: Q4 2025 in Review

Jane Street sold out of Takeda Pharmaceutical (TAK) in Q4 2025, closing a stake of 106,290 shares — an estimated $1.56M sold.

Jane Street first reported a position in TAK in Q4 2018 and held it in 26 quarters. The position peaked at $16.3M in Q4 2023. 348 funds tracked by Wall St. Rank hold TAK as of Q4 2025.

Jane Street reported no remaining Takeda Pharmaceutical position as of Q4 2025 after selling out during the quarter.
Jane Street sold 106,290 Takeda Pharmaceutical shares in Q4 2025, an estimated $1.56M.
Jane Street first reported a position in Takeda Pharmaceutical in Q4 2018 and held it in 26 quarters.
Jane Street's Takeda Pharmaceutical position peaked at $16.3M in Q4 2023.
348 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2025.

Based on Jane Street's 13F filing for Q4 2025, filed 12 Feb 2026.